SynAct Pharma to participate at Kempen’s virtual Life Sciences Conference

SynAct Pharma AB ("SynAct") today announced that the company will participate at the virtual meeting Kempen Life Sciences Conference – 2021 Thematic Virtual Series, on May 5.

The presentation will be available via SynAct’s website:

More information about the event is available at the organizer’s website:

The information was submitted, through the agency of the contact persons below, for publication on April 30, 2021.

For further information about SynAct Pharma AB, please contact:

Jeppe Øvlesen                                                                                Thomas Jonassen

CEO, SynAct Pharma AB                                                               CSO, SynAct Pharma AB

Phone: +45 28 44 75 67                                                                 Phone: +45 40 15 66 69

Mail:                                                        Mail: